Several meta-analysis studies indicated that the ESR1 PvuII polymorphism was associated with high risk of BC in pre-menopausal in comparison with post-menopausal women (Cai et al., 2003; González-Zuloeta Ladd et al., 2008). This evidence concerns the gene ESR1 and breast cancer.